“a nonsignificant trend”

Log-transformed NT-proBNP decreased significantly at 2-month follow-up (3.03 vs 2.82; P = .013), with a nonsignificant trend between NT-proBNP and lead position (η 2 = 0.220; P = .199) ( Figure 4 C).

Results Patients showed lower myostatin values (978.48 ± 805.84 pg/mL) than controls (1440.89 ± 479.62 pg/mL, Z = 3.80; p < 0.001, Figure 1 ), although patients with cirrhosis showed a nonsignificant trend to higher values (996.10 ± 810.13 pg/mL) than patients without cirrhosis (963.61 ± 814.86 pg/mL; Z = 0.24; p > 0.20; NS).

A nonsignificant trend toward a shorter duration in drug to extubation (MD: 0.31, 95% CI [−0.17, 0.78], P = 0.200), operating room discharge (MD: 0.28, 95% CI [−0.24, 0.80], P = 0.290), PACU entry (MD: 0.12, 95% CI [−0.37, 0.60], P = 0.640), and PACU stay (MD: 0.31, 95% CI [−0.96, 1.58], P = 0.630) was observed in the PtDA group compared with the classical group ( Table 4 ).

27 used the PHQ-4 questionnaire and showed a nonsignificant trend toward reduction in depression postcounseling for the remote group ( p = 0.2) and in-person group ( p = 0.16).

Overall survival according to R resection status for the 26 resected patients is shown in Figure 2 and indicates a nonsignificant trend for improved survival in the R0 vs R1 group (HR 2.1; 95% CI 0.7–7.0; P =0.2).

Metastatectomy alone (N = 16) showed a nonsignificant trend toward improved survival (HR: 0.59; 95% CI: 0.27–1.28; p = 0.20).

Interestingly, a nonsignificant trend towards a decreased mean number of CaMKII immunogold particles was observed in spines (39% decrease, P = 0.20) and PSDs (62% decrease, P = 0.12, Figure 1(d) , Table 1 ), with no apparent change in the mean number of pCaMKII immunogold particles in boutons, spines, or PSDs ( Figure 1(d) , Table 2 ).

In comparison to old WT mice liver, a nonsignificant trend of increased acetylation (1.9 fold change, P = 0.2, Dataset S3 ) was found.

Similarly, T4 demonstrated a negative slope for shorter sleep (β = –0.280; 95% CI –0.390 to –0.170; p < 0.001) and a nonsignificant trend for longer durations (β = –0.060; p = 0.20).

Influence of LT and ACD on Absolute Prediction Error Overall, shallower anterior chambers were significantly associated with higher AbsPE ( p = 0.003), whereas LT showed only a nonsignificant trend ( p = 0.2).

Higher compliance had a nonsignificant trend for reducing the incidence of incisional SSI (P=0.20) ( Fig. 2 ).

This analysis displayed a nonsignificant trend for an association with CSS when expression was scored in Oxford (log rank test, P = .20) but was not seen in scores from Manchester ( Fig. 3 c and 3d).

While ALT had a nonsignificant trend (−0.56 (−1.54, 0.41); P = .20), ALT was noted to decrease significantly in CF patients (−0.90 (−1.71, −0.08); P = .037).

Combined data demonstrate that vitamin D supplementation did not significantly effect 2HPG, but a nonsignificant trend was found for decreased 2HPG by –0.13 mmol/L (95% CI: –0.34 to 0.08; P = 0.2, I 2 = 69.1%; Fig. 6 ).

There was a nonsignificant trend toward a decreasing proportion of specimens with protective immunity over the 5 weeks from which the September specimens were taken (p = 0.20, by χ 2 test for trend).

PD-L1 CPS was not associated with outcomes and TMB had a nonsignificant trend of correlation with pCR (median TMB 26 in non-pCR vs 40 in pCR group, P = 0.2) [ 13 ].

Relative to baseline, at 3 weeks post-CRT, there was a nonsignificant trend towards improvement in scores for loss of appetite ( P =0.20), dyspnea ( P =0.13), haemoptysis ( P =0.14), pain ( P =0.36), overall symptomatic distress ( P =0.19) and overall QOL ( P =0.54) after CRT ( Table 6 ).

Comparison to randomized networks showed a nonsignificant trend ( P = 0.2; 28 ± 4 in randomized networks).

We observed a nonsignificant trend between CBF and cardiovascular events (OR = 0.80, CI 95% =−0.71, 1.10, p-value = 0.20).

We observed a nonsignificant trend toward lower platelet cAMP ( P = .204) in aPL + patients with a history of thrombosis compared with those without such a history ( supplemental Figure 1 ).

At night, sleep duration increased in both groups from baseline to week 24 LOCF, and there was a nonsignificant trend for a greater increase in the ropinirole prolonged release group (adjusted mean treatment difference [AMTD], 0.16; 95% confidence interval [CI]: −0.09, 0.41; P = 0.2041).

Current smokers exhibited substantially higher odds than never smokers (OR: 1.57; 95% CI: 1.35–1.82; P < .001), while former smokers showed a nonsignificant trend towards an increased risk (OR: 1.11; 95% CI: 0.95–1.29; P = .207).

Based on the Mann-Kendall test, the z score of –1.25 indicated a nonsignificant trend ( P =.21).

In patients referred for haploidentical transplantation, there was a nonsignificant trend toward improved cEFS with transplantation: the 2‐year cEFS was 54% (95% CI: 33%–89%) versus 44% (95% CI: 26%–76%) without transplantation (P = 0.21) (Supporting Information S1: Figure 1C,D ).

Of these 70 patients (36 completing myeloablative consolidation and 34 completing nonmyeloablative consolidation), there was a nonsignificant trend for longer PFS in the myeloablative arm than the nonmyeloablative arm (HR, 0.58; 95% CI, 0.25-1.36; P = .21), with estimated 2-year PFS rates after the start of consolidation of 86% (95% CI, 69-94) vs 71% (95% CI, 52-83), respectively ( Figure 3 B).